Prolactinoma epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{Faizan}} | {{CMG}} {{AE}}{{Faizan}} | ||
==Overview== | ==Overview== | ||
The prevalence of prolactinoma in younger age group is 100 per 100,000 individuals.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> Clinically significant pituitary [[tumors]] affect approximately 14 out of 100,000 people in United States. | The prevalence of prolactinoma in younger age group is 100 per 100,000 individuals worldwide.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> Clinically significant pituitary [[tumors]] affect approximately 14 out of 100,000 people in United States. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The [[prevalence]] of prolactinoma in younger age group is 100 per 100,000 individuals.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> Clinically significant [[pituitary]] tumors affect the health of approximately 14 out of 100,000 people in United States. Some [[growth hormone]] producing tumors also co-secrete [[prolactin]]. Microprolactinomas are much more common than macroprolactinomas. | The [[prevalence]] of prolactinoma in younger age group is 100 per 100,000 individuals worldwide.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062 }} </ref> Clinically significant [[pituitary]] tumors affect the health of approximately 14 out of 100,000 people in United States. Some [[growth hormone]] producing tumors also co-secrete [[prolactin]]. Microprolactinomas are much more common than macroprolactinomas. | ||
===Age=== | ===Age=== | ||
Revision as of 19:52, 11 September 2015
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Prolactinoma epidemiology and demographics |
|
Risk calculators and risk factors for Prolactinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
The prevalence of prolactinoma in younger age group is 100 per 100,000 individuals worldwide.[1] Clinically significant pituitary tumors affect approximately 14 out of 100,000 people in United States.
Epidemiology and Demographics
The prevalence of prolactinoma in younger age group is 100 per 100,000 individuals worldwide.[1] Clinically significant pituitary tumors affect the health of approximately 14 out of 100,000 people in United States. Some growth hormone producing tumors also co-secrete prolactin. Microprolactinomas are much more common than macroprolactinomas.
Age
Prolactinomas occur more often in adolescents. It rarely occur in children.
Gender
Prolactinomas occur more often in women than men.
References
- ↑ 1.0 1.1 Ciccarelli A, Daly AF, Beckers A (2005). "The epidemiology of prolactinomas". Pituitary. 8 (1): 3–6. doi:10.1007/s11102-005-5079-0. PMID 16411062.